Cerity Partners’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
MC
WA
Cerity Partners's RGEN Position: Q2 2026 in Review
Cerity Partners reduced its Repligen (RGEN) stake by 2% in Q2 2026, selling an estimated $7.25K and leaving 2,851 shares worth $389K. The position accounts for ﹤0.01% of the portfolio, ranked #2601.
Cerity Partners first reported a position in RGEN in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.33M in Q1 2023. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Cerity Partners held 2,851 shares of Repligen worth $389K as of Q2 2026.
- Cerity Partners sold 59 Repligen shares in Q2 2026, an estimated $7.25K.
- Repligen made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2601 holding.
- Cerity Partners first reported a position in Repligen in Q4 2021 and has held it in 18 quarters since.
- Cerity Partners's Repligen position peaked at $1.33M in Q1 2023.
- 444 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.